...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Additional Exempt Distributions
2
Sep 17, 2023 04:45PM

Additional Exempt Distribution Report:

2023-09-26

Alberta: Promissory Note, $337,725.00 CAN,

with 450 K Warrants @ $1.01 Expire 2029-09-26

This brings a total of new financing for 2023 in the amount of $12,249,330 CAN. This includes the amounts I posted on Sep 17, 2023, at 04:45 PM.

More than not, all the Promissory Notes were made by Don M.

 

Koo

 

 

 

Share
New Message
Please login to post a reply